Abstract

Ten new N-(aryl/coclohexyl thiocarbomoyl) sulfaniyl 2-(2-benzothiazolyl) hydrazides have been prepared and evaluated for their oral hypoglycemic activity against the streptozotocin-induced diabetic rats. One of them (IVi) has been found to be efficent in reducing the blood sugar levels.